GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » Enterprise Value

Atrys Health (XMAD:ATRY) Enterprise Value : €512.2 Mil (As of Jun. 07, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Atrys Health Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Atrys Health's Enterprise Value is €512.2 Mil. Atrys Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.6 Mil. Therefore, Atrys Health's EV-to-EBIT ratio for today is -789.26.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Atrys Health's Enterprise Value is €512.2 Mil. Atrys Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €29.0 Mil. Therefore, Atrys Health's EV-to-EBITDA ratio for today is 17.65.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Atrys Health's Enterprise Value is €512.2 Mil. Atrys Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €201.6 Mil. Therefore, Atrys Health's EV-to-Revenue ratio for today is 2.54.


Atrys Health Enterprise Value Historical Data

The historical data trend for Atrys Health's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Enterprise Value Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 155.22 363.13 735.91 693.37 497.81

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 735.91 688.77 693.37 632.66 497.81

Competitive Comparison of Atrys Health's Enterprise Value

For the Biotechnology subindustry, Atrys Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Atrys Health's Enterprise Value falls into.



Atrys Health Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Atrys Health's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Atrys Health's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health  (XMAD:ATRY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Atrys Health's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=512.231/-0.649
=-789.26

Atrys Health's current Enterprise Value is €512.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Atrys Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.6 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Atrys Health's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=512.231/29.024
=17.65

Atrys Health's current Enterprise Value is €512.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Atrys Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €29.0 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Atrys Health's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=512.231/201.569
=2.54

Atrys Health's current Enterprise Value is €512.2 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Atrys Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €201.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health Enterprise Value Related Terms

Thank you for viewing the detailed overview of Atrys Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health (XMAD:ATRY) Business Description

Traded in Other Exchanges
Address
c/ Provença, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines